Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 1;9(1):522-554.
doi: 10.1080/21505594.2017.1313372.

Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action

Affiliations
Review

Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action

Ranita Roy et al. Virulence. .

Abstract

Biofilm refers to the complex, sessile communities of microbes found either attached to a surface or buried firmly in an extracellular matrix as aggregates. The biofilm matrix surrounding bacteria makes them tolerant to harsh conditions and resistant to antibacterial treatments. Moreover, the biofilms are responsible for causing a broad range of chronic diseases and due to the emergence of antibiotic resistance in bacteria it has really become difficult to treat them with efficacy. Furthermore, the antibiotics available till date are ineffective for treating these biofilm related infections due to their higher values of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), which may result in in-vivo toxicity. Hence, it is critically important to design or screen anti-biofilm molecules that can effectively minimize and eradicate biofilm related infections. In the present article, we have highlighted the mechanism of biofilm formation with reference to different models and various methods used for biofilm detection. A major focus has been put on various anti-biofilm molecules discovered or tested till date which may include herbal active compounds, chelating agents, peptide antibiotics, lantibiotics and synthetic chemical compounds along with their structures, mechanism of action and their respective MICs, MBCs, minimum biofilm inhibitory concentrations (MBICs) as well as the half maximal inhibitory concentration (IC50) values available in the literature so far. Different mode of action of anti biofilm molecules addressed here are inhibition via interference in the quorum sensing pathways, adhesion mechanism, disruption of extracellular DNA, protein, lipopolysaccharides, exopolysaccharides and secondary messengers involved in various signaling pathways. From this study, we conclude that the molecules considered here might be used to treat biofilm-associated infections after significant structural modifications, thereby investigating its effective delivery in the host. It should also be ensured that minimum effective concentration of these molecules must be capable of eradicating biofilm infections with maximum potency without posing any adverse side effects on the host.

Keywords: anti-biofilm molecules; antimicrobial peptide; biofilm formation; biofilm model; drug resistance; herbal molecules.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic representation of overview of the targets of anti-biofilm molecules.
Figure 2.
Figure 2.
Structures of the anti-biofilm molecules that inhibit AHL-mediated quorum sensing. (a) EGCG, (b) Quercetin, (c) Synthetic halogenated furanone, (d) Reserpine, (e) Curcumin, (f) Ellagic acid, (g) Tannic acid.
Figure 3.
Figure 3.
Structures of the anti-biofilm molecules that inhibit the stringent response. (a) Eugenol.
Figure 4.
Figure 4.
Structure of anti biofilm molecules that disassemble the biofilm. (a) Berberine, (b) Usnic acid.
Figure 5.
Figure 5.
Structures of the anti-biofilm molecules that inhibit lipopolysachharides. (a) Colistin (Polymixin E), (b) Polymixin B274,275, (c) Gramicidin S276, (d) Sushi peptide (S1 domain).
Figure 6.
Figure 6.
Structures of the anti-biofilm molecules that alter the membrane potential or membrane permeabilization. (a) Nisin, (b) Subtilin, (c) Epidermin, (d) Gallidermin, (e) Chlorhexidine, (f) Sophorolipid, (g) Polyhexamethylene biguanide.
Figure 7.
Figure 7.
Structures of the anti-biofilm molecules that inhibit cell division and survival. (a) Microcin B17, (b) Chitosan, (c) Pyrrhocoricin, (d) Sodium Citrate, (e) Tetrasodium EDTA.
Figure 8.
Figure 8.
Structures of the anti-biofilm molecules that Inhibit adhesion molecule synthesis and function (a) Cadexomer iodine, (b) LL-37291.
Figure 9.
Figure 9.
Structures of the anti-biofilm molecules that inhibit polysaccharides. (a) Psl polysaccharide, (b) Pel polysaccharide, (c) CFT073 group-II capsular polysaccharide (Serotype K2).
Figure 10.
Figure 10.
Structures of the antibiofilm molecules with unknown mechanism of action. (a) Esculetin, b) Fisetin, c) Octenidine hydrochloride.

References

    1. Alhede M, Kragh KN, Qvortrup K, Allesen-Holm M, van Gennip M, Christensen LD, Jensen PØ, Nielsen AK, Parsek M, Wozniak D, et al.. Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. PloS One 2011; 6:e27943; PMID:22132176; https://doi.org/10.1371/journal.pone.0027943 - DOI - PMC - PubMed
    1. Bjarnsholt T, Jensen PO, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, Pressler T, Givskov M, Høiby N. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 2009; 44:547-58; PMID:19418571; https://doi.org/10.1002/ppul.21011 - DOI - PubMed
    1. Haaber J, Cohn MT, Frees D, Andersen TJ, Ingmer H. Planktonic aggregates of Staphylococcus aureus protect against common antibiotics. PloS One 2012; 7:e41075; PMID:22815921; https://doi.org/10.1371/journal.pone.0041075 - DOI - PMC - PubMed
    1. Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2003; 2:114-22; PMID:12563302; https://doi.org/10.1038/nrd1008 - DOI - PubMed
    1. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000; 407:762-4; PMID:11048725; https://doi.org/10.1038/35037627 - DOI - PubMed

Publication types

MeSH terms

Substances